Funding round-up: Vector BioPharma, Eka Care, Structure Therapeutics, F2G, Eleven Therapeutics

Israel: Eleven Therapeutics, a biotech company focused on using AI in nucleic acid therapeutics, has raised a total of US$22m in seed funding. Among the funders is the Bill & Melinda Gates Foundation, which committed US$9m, including US$5m towards future equity investment supporting the development of a platform that designs small interfering RNAs (siRNAs) with ultra-long durability by utilising high throughput…

You must be a HMI Subscriber to view this content.

Subscribe Now »